Not Yet Recruiting NA INTERVENTIONAL 1-arm NCT06744712

Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients

Sponsor: Atrium Health Levine Cancer Institute

Updated 8 times since 2025 Last updated: Jan 6, 2026 Started: Mar 31, 2026 Primary completion: Aug 31, 2027 Completion: Jul 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Pediatric Cancer, this trial is actively recruiting participants. The trial is conducted by Atrium Health Levine Cancer Institute and has accumulated 8 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Not Yet Recruiting NA
Jan 2026 — Feb 2026 [monthly]

Not Yet Recruiting NA
Oct 2025 — Jan 2026 [monthly]

Not Yet Recruiting NA
Aug 2025 — Oct 2025 [monthly]

Not Yet Recruiting NA
Jul 2025 — Aug 2025 [monthly]

Not Yet Recruiting NA

▶ Show 3 earlier versions

May 2025 — Jul 2025 [monthly]

Not Yet Recruiting NA
Mar 2025 — May 2025 [monthly]

Not Yet Recruiting NA
Jan 2025 — Mar 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atrium Health Levine Cancer Institute
OneOme, LLC
Wake Forest University Health Sciences

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlotte, United States